Related Experiment Video
Updated: Jun 7, 2026

Visualization of Replisome Encounters with an Antigen Tagged Blocking Lesion
Published on: July 27, 2021
Cdc5 blocks in vivo Rad53 activity, but not in situ activity (ISA)
Jaime Lopez-Mosqueda1, Genevieve M Vidanes, David P Toczyski
1Dept. of Biochemistry and Biophysics, University of California, San Francisco, USA.
Abstract:
DNA damage promotes the activation of a signal transduction cascade referred to as the DNA damage checkpoint. This pathway initiates with the Mec1/ATR kinase, which then phosphorylates the Rad53/Chk2 kinase. Mec1 phosphorylation of Rad53 is then thought to promote Rad53 autophosphorylation, ultimately leading to a fully active Rad53 molecule that can go on to phosphorylate substrates important for DNA damage resistance. In the absence of DNA repair, this checkpoint is eventually downregulated in a Cdc5-dependent process referred to as checkpoint adaptation. Recently, we showed that overexpression of Cdc5 leads to checkpoint inactivation and loss of the strong electrophoretic shift associated with Rad53 inactivation. Interestingly, this same overexpression did not strongly inhibit Rad53 autophosphorylation activity as measured by the in situ assay (ISA). The ISA involves incubating the re-natured Rad53 protein with γ ³²P labeled ATP after electrophoresis and western blotting. Using a newly identified Rad53 target, we show that despite strong ISA activity, Rad53 does not maintain phosphorylation of this substrate. We hypothesize that, during adaptation, Rad53 may be in a unique state in which it maintains some Mec1 phosphorylation, but does not have the auto-phosphorylations required for full activity towards exogenous substrates.
Insights
DNA damage triggers a checkpoint pathway involving Mec1/ATR and Rad53/Chk2 kinases. Checkpoint adaptation, regulated by Cdc5, inactivates this pathway, but Rad53 retains some activity, impacting DNA repair.
Area of Science:
- Cellular biology
- Molecular genetics
- Biochemistry
Background:
- DNA damage activates a checkpoint pathway initiated by Mec1/ATR kinase.
- Mec1/ATR phosphorylates Rad53/Chk2, promoting its autophosphorylation and full activation.
- Checkpoint adaptation, a Cdc5-dependent process, downregulates the DNA damage checkpoint in the absence of repair.
Purpose of the Study:
- To investigate the activity state of Rad53/Chk2 during checkpoint adaptation.
- To determine if Rad53/Chk2 retains substrate phosphorylation activity despite checkpoint inactivation.
Main Methods:
- Overexpression of Cdc5 to induce checkpoint adaptation.
- In situ assay (ISA) to measure Rad53/Chk2 autophosphorylation activity.
- Analysis of a novel Rad53/Chk2 target phosphorylation.
Main Results:
- Cdc5 overexpression inactivated the checkpoint and abolished the Rad53/Chk2 electrophoretic shift.
- Rad53/Chk2 retained significant autophosphorylation activity via ISA.
- Despite ISA activity, Rad53/Chk2 failed to phosphorylate a newly identified exogenous substrate.
Conclusions:
- Checkpoint adaptation involves a unique Rad53/Chk2 state with partial Mec1/ATR phosphorylation but lacking autophosphorylations for full exogenous substrate activity.
- Rad53/Chk2 inactivation during adaptation is substrate-specific, not a complete loss of kinase function.
More Related Videos
Related Concept Videos
In vitro Mutagenesis
In-vitro Mutagenesis
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks

